Document is current
Any future updates will be listed below
-
Authors
Boinpally, Ramesh R. https://orcid.org/0000-0001-8267-9210
Smith, Jonathan H. https://orcid.org/0000-0002-2798-6805
De Abreu Ferreira, Rosa L. https://orcid.org/0000-0001-5525-1032
Trugman, Joel M. https://orcid.org/0000-0002-2376-8878
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05892757 at ClinicalTrials.govDocuments that mention this clinical trial
Pharmacokinetics of Atogepant in Healthy Lactating Female Participants: Results from a Phase 1 Lactation Study
https://doi.org/10.1007/s40120-025-00772-4
-
Funding
Funding for this research was provided by:
AbbVie
- License Information
-
More Information
Article History
Received: 8 April 2025
Accepted: 12 May 2025
First Online: 2 June 2025
Declarations
:
: Ramesh R Boinpally, Jonathan H Smith, and Rosa L De Abreu Ferreira are employees of AbbVie and may hold AbbVie stock or options. Joel M Trugman is a former employee of AbbVie and may hold AbbVie stock or options.
: The studies reported herein were conducted in compliance with the International Council for Harmonisation (ICH) guidelines, guidelines governing clinical study conduct and the ethical principles that have their origin in the Declaration of Helsinki and applicable regulations. Institutional Review Boards and Independent Ethics Committees at participating institutions approved the study prior to study initiation at ICON sites in Salt Lake City, Utah, USA and San Antonio, Texas, USA (Advarra IRB; IRB00000971), and Bio-Kinetic Clinical Applications, LLC in Springfield, Missouri, USA (Bio-Kinetic Clinical Applications IRB; IRB00002771). An informed consent was obtained from all individuals who participated in this study.
